What treatment options are available for a 45‑year‑old patient with bone‑on‑bone knee osteoarthritis?

Treatment Options for Bone-on-Bone Knee Osteoarthritis in a 45-Year-Old

For a 45-year-old with severe (bone-on-bone) knee osteoarthritis, begin with combined weight loss and exercise therapy, add topical NSAIDs as first-line pharmacotherapy, and consider intra-articular corticosteroid injections for symptom control while recognizing that total knee replacement will likely be necessary given the severity of disease at this young age.

Core Non-Pharmacologic Interventions

Weight Management and Exercise (First-Line)

• Sustained weight loss through combined diet and exercise is strongly recommended and provides the most robust evidence for improving pain and function 1.
• Weight loss benefits pain more than function, but carries no risk and provides substantial other health benefits 1.
• Exercise therapy is a cornerstone intervention with strong evidence across all guidelines 1, 2.
• These interventions should be implemented immediately and maintained throughout treatment 1.

Patient Education

• Self-management education is consistently recommended across all high-quality guidelines 2, 3.
• Education should address realistic expectations, particularly given the severity of disease (bone-on-bone) at age 45 4, 5.

Pharmacologic Management

Topical Therapies (Preferred Initial Pharmacotherapy)

• Topical NSAIDs are strongly recommended for knee osteoarthritis as they provide systemic medication benefits with minimal systemic exposure 1.
• Topical NSAIDs should be considered before oral NSAIDs due to superior safety profile 1.
• Topical capsaicin is conditionally recommended but has small effect sizes 1.

Oral Medications

• Oral NSAIDs (both nonselective and COX-2 selective) consistently demonstrate improved pain and function 1, 6.
• Both types of NSAIDs are equally effective, with no notable difference in gastrointestinal adverse events between nonselective and COX-2 selective agents 1.
• Critical caveat: Both acetaminophen and NSAIDs carry FDA black box warnings requiring careful prescribing 1.
• Oral narcotics including tramadol should NOT be used due to increased adverse effects without consistent improvement in pain or function 1, 6.

Intra-Articular Injections

Corticosteroid Injections (Recommended)

• Intra-articular corticosteroids are supported by 19 high-quality and 6 moderate-quality studies 1.
• Provide short-term pain relief, typically lasting approximately 3 months 1, 4.
• Have relatively minor adverse effects and are appropriate for selected cases 1, 6, 3.

Hyaluronic Acid (Not Routinely Recommended)

• Not consistently supported by evidence (17 high-quality and 11 moderate-quality studies showed inconsistent results) 1.
• The number needed to treat is 17 patients, but evidence does not identify which subset benefits 1.
• Recommendation is against routine use 1.
• Higher-quality guidelines consistently recommend against hyaluronic acid 2.

Platelet-Rich Plasma (Limited Evidence)

• Supported by 2 high-quality and 1 moderate-quality study showing reduced pain and improved function 1.
• Critical limitation: Evidence shows worse treatment response in patients with severe osteoarthritis (bone-on-bone) 1.
• Concerns exist regarding cost and safety profile 1.
• Higher-quality guidelines consistently recommend against stem cell injections 2.

Emerging Therapies

Regenerative Approaches

• Recent evidence (2026) shows adipose-derived stem cell therapy provides meaningful symptom relief, but benefits are significantly attenuated in advanced (KL grade 4/bone-on-bone) disease compared to moderate disease 7.
• This suggests limited regenerative potential in end-stage disease at the severity level described 7.

Other Emerging Options

• Genicular nerve radiofrequency ablation shows early promise but lacks long-term comparative data 3, 5.
• Gene therapies and other novel approaches are under investigation but not yet guideline-recommended 8, 5.

Interventions to Avoid

Strongly Recommended Against

• Oral narcotics and tramadol due to increased adverse effects without consistent benefit 1.
• Arthroscopy is consistently recommended against in higher-quality guidelines for degenerative knee osteoarthritis 2.
• TENS (transcutaneous electrical nerve stimulation) is strongly recommended against due to lack of benefit 1.
• Massage therapy, manual therapy added to exercise alone, and pulsed vibration therapy are conditionally recommended against 1.

Uncertain Benefit

• Dietary supplements (glucosamine, chondroitin, turmeric, ginger, vitamin D) show inconsistent evidence with minimal risks but represent out-of-pocket expenses 1.

Critical Considerations for This Patient

Age and Disease Severity

• At age 45 with bone-on-bone disease, this patient has severe osteoarthritis at a relatively young age 4.
• The reduced physical activity from severe OA leads to 20% higher age-adjusted mortality, emphasizing the importance of maintaining activity 4.
• Total joint replacement is the definitive treatment for advanced symptoms and structural damage 4, 5.

Surgical Timing

• While no higher-quality guidelines specifically addressed arthroplasty timing 2, the severity of disease (bone-on-bone) in a 45-year-old suggests eventual need for replacement.
• Non-operative management should be maximized first, but realistic expectations about progression should be discussed 3, 5.

Implementation Strategy

1. Immediate initiation: Weight loss program (if overweight/obese) + structured exercise + education 1, 2
2. Add topical NSAIDs as first-line pharmacotherapy 1
3. Consider oral NSAIDs if topical therapy insufficient, with attention to contraindications and black box warnings 1
4. Intra-articular corticosteroid injections for symptom control (expect ~3 months benefit) 1
5. Avoid hyaluronic acid, PRP, and stem cell therapies given the severe disease stage and inconsistent evidence 1, 7, 2
6. Plan for eventual total knee replacement discussion as definitive treatment 4, 5